World Mental Health Day 2024

October 10, 2024

Celebrating Progress in Mental Health Care

On World Mental Health Day, we reflect on the strides being made in mental health care and the hope that new therapies bring. A recent breakthrough—a safer treatment for agitation in schizophrenia and bipolar disorders—embodies this progress. CRC is proud to have supported the clinical trials that led to FDA approval, staying true to our mission of improving patients’ lives.

Transforming Patient Care Through Collaboration

This new therapy offers a safer, more compassionate way to manage agitation, giving patients and healthcare providers more control in critical moments. The approval underscores the power of teamwork and dedication. Micah Humphrey, one of the many contributors to the project’s success, shared his excitement for this important milestone.

A picture of a man with a quote by mitch humphrey

A Lasting Commitment to Global Mental Health


With nearly 970 million people worldwide affected by mental health conditions, CRC is honored to have supported 15 FDA-approved CNS treatments. On this World Mental Health Day, we thank all those working tirelessly to improve mental health. Our shared commitment to advancing life-changing therapies continues to drive us forward.

Check Out the Full Case Study to Learn More

Dementia patient and doctor in clinical setting related to agitation trial
July 30, 2025
Discover how CRC managed rater complexity and timelines in an agitation study using customized training and algorithmic oversight.
Alzheimer's patient with doctor
July 15, 2025
Discover how CRC supported a novel Alzheimer’s program through first-in-human (FIH), Phase Ib/IIa, and OLE trials with precision, urgency, and trusted oversight.
Illustration of active brain neurons highlighting neural pathways
July 1, 2025
GLP-1 receptor agonists may offer a new path for treating addiction and mental health challenges, emerging as a versatile class in CNS clinical research.
Show More